Collaborative study on influenza vaccine clinical trial serology - part 2: reproducibility study.

Pharmeuropa bio & scientific notes

Volumn 2011, Issue 1, 2011, Pages 36-54

  Wood, J M ^a   Montomoli, E ^b   Newman, R W ^b   Daas, A ^b   Buchheit, K H ^b   Terao, E ^b  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); EPIDEMIOLOGY; EUROPE; EVALUATION; HEMAGGLUTINATION INHIBITION TEST; HEMOLYSIS; HUMAN; IMMUNOLOGY; INTERNATIONAL COOPERATION; LABORATORY; METHODOLOGY; MULTICENTER STUDY; OBSERVER VARIATION; PRACTICE GUIDELINE; REPRODUCIBILITY; SEROLOGY; STANDARD;

BIAS (EPIDEMIOLOGY); CLINICAL TRIALS AS TOPIC; EUROPE; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HEMAGGLUTINATION INHIBITION TESTS; HEMOLYSIS; HUMANS; INFLUENZA VACCINES; INTERNATIONAL COOPERATION; LABORATORIES; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SEROLOGIC TESTS;

EID: 80052344794     PISSN: 20752164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)